The latest price target for Bruker (NASDAQ:BRKR) was reported by Guggenheim on January 17, 2025. The analyst firm set a price target for $0.00 expecting BRKR to fall to within 12 months (a possible -100.00% downside). 23 analyst firms have reported ratings in the last year.

The latest analyst rating for Bruker (NASDAQ:BRKR) was provided by Guggenheim, and Bruker reiterated their buy rating.

The last upgrade for Bruker Corp happened on December 5, 2024 when Goldman Sachs raised their price target to $60. Goldman Sachs previously had a sell for Bruker Corp.

The last downgrade for Bruker Corp happened on September 30, 2024 when Wolfe Research changed their price target from N/A to N/A for Bruker Corp.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bruker, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bruker was filed on January 17, 2025 so you should expect the next rating to be made available sometime around January 17, 2026.

While ratings are subjective and will change, the latest Bruker (BRKR) rating was a reiterated with a price target of $0.00 to $0.00. The current price Bruker (BRKR) is trading at is $58.27, which is out of the analyst’s predicted range.